Liposomal bupivacaine is a formulation of local anesthetic which has the potential to provide anesthesia for up to 72 hours following administration. The purpose of this study was to compare the ...

[1,5,9,10,12] Liposomal bupivacaine is a novel method of local anesthetic delivery, and obviates the need for nerve blocks and catheter placement. In the present study, patients treated with ...

The results indicated that a single injection of liposomal bupivacaine resulted in better pain control and reduced narcotic consumption compared to the catheter method, along with lower overall ...

To study postoperative pain control differences between liposomal bupivacaine (LB) and immediate-release bupivacaine (IRB) as measured by the use of narcotics after iliac crest graft harvesting for ...

Clinicians, discover the latest in research and clinical innovation from Johns Hopkins experts. Access educational videos, articles, CME courses and other resources from our world-renowned institution ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

One study investigated the effects of diabetic peripheral neuropathy on the duration of sciatic nerve blocks using liposomal bupivacaine and standard bupivacaine in a mouse model. The results ...

Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer ---- Key additions expected to support company’s ...

Accomplished Business and Financial Leader, Laura Brege, Appointed Chair ---- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of ...

Other revenue, including sales of bupivacaine liposome injectable suspension ... to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years ...

Prompt injection is the highest profile vulnerability in AI-powered features and applications. It's also one of the most misunderstood. The impact varies greatly depending on who will use the feature, ...

Recent pan-cancer analysis revealed the global pattern and potential aetiologies of copy number variation signatures in human cancers, particularly those derived from non-hematopoietic tissues. In ...